[en] The Imaging Task Force appointed by the European Society of Cardiology (ESC) and the European Association of Cardiovascular Imaging (EACVI) identified the need to develop appropriateness criteria for the use of cardiovascular imaging in heart failure as a result of continuously increasing demand for imaging in diagnosis, definition of aetiology, follow-up, and treatment planning. This article presents the report of literature review performed in order to inform the process of definition of clinical indications and to aid the decisions of the appropriateness criteria voting panel. The report is structured according to identified common heart failure clinical scenarios.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Garbi, Madalina; King's Health Partners, King's College Hospital NHS Foundation Trust, London, United Kingdom
McDonagh, T.; King's Health Partners, King's College Hospital NHS Foundation Trust, London, United Kingdom
Cosyns, Bernard; Universitair Ziekenhuis Van Brussel, CHVZ and ICMI Laboratory, CHIREC, Brussels, Belgium
Bucciarelli-Ducci, C.; Bristol Heart Institute, University Hospitals Bristol NHS Foundation Trust, University of Bristol, Bristol, United Kingdom
Edvardsen, Thor; Department of Cardiology, Oslo University Hospital, Rikshospitalet and University of Oslo, Norway
Nieman, K.; Department of Cardiology and Radiology, Erasmus MC, Rotterdam, Netherlands
Lancellotti, Patrizio ; Université de Liège - ULiège > Département des sciences cliniques > Imagerie cardiaque fonctionnelle par échographie
Language :
English
Title :
Appropriateness criteria for cardiovascular imaging use in heart failure: report of literature review.
Publication date :
2015
Journal title :
European Heart Journal. Cardiovascular Imaging
ISSN :
2047-2404
eISSN :
2047-2412
Publisher :
Oxford University Press, United Kingdom
Volume :
16
Issue :
2
Pages :
147-153
Peer reviewed :
Peer Reviewed verified by ORBi
Commentary :
Published on behalf of the European Society of Cardiology. All rights reserved. (c) The Author 2014. For permissions please email: journals.permissions@oup.com.
McMurray JJV, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012. Eur Heart J 2012;33:1787-847.
Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93:1137-46.
Bui A, Horwich T, Fonarow G. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30-41.
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography,a registered branchof the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713.
Dokainish H, Nguyen JS, Bobek J, Goswami R, Lakkis NM. Assessment of the American Society of Echocardiography-European Association of Echocardiography guidelines for diastolic function in patients with depressed ejection fraction: an echocardiographic and invasive haemodynamic study. Eur J Echocardiogr 2011;12:857-64.
Kirkpatrick JN, Vannan MA, Narula J, Lang RM. Echocardiography in heart failure: applications, utility, and new horizons. J Am Coll Cardiol 2007;50:381-96.
Lancellotti P, Tribouilloy C, Hagendorff A, Popescu BA, Edvardsen T, Pierard LA et al. On behalf of the European Association of Cardiovascular Imaging: Recommendations for the Assessment of Native Valvular Regurgitation: An Executive Revised Summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 2013;14:611-44.
Lancellotti P, Moura L, Pierard LA, Agricola E, Popescu BA, Tribouilloy C et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010;11:307-32.
Lancellotti P, Tribouilloy C, Hagendorff A, Moura L, Popescu BA, Agricola E et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010;11:223-44.
Popescu BA, Stefanidis A, Nihoyannopoulos P, Fox KF, Ray S, Cardim N et al. Updated standards and processes for accreditation of echocardiographic laboratories from The European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2014;15:717-27.
Popescu BA, Andrade MJ, Badano LP, Fox KF, Flachskampf FA, Lancellotti P et al. European Association of Echocardiography recommendations for training, competence, and quality improvement in echocardiography. Eur J Echocardiogr 2009;10:893-905.
Nagueh SF, Bhatt R, Vivo RP, Krim SR, Sarvari SI, Russell K et al. Echocardiographic evaluation of hemodynamics inpatients with decompensated systolic heart failure. Circ Cardiovasc Imaging 2011;4:220-7.
Sicari R, Nihoyannopoulos P, Evangelista A, Kasprzak J, Lancellotti P, Poldermans D et al. Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC). Eur J Echocardiogr 2008;9:415-37.
Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE et al. Howto diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-50.
Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006;7:79-108.
Lang RM, Badano LP, Tsang W, Adams DH, Agricola E, Buck T et al. EAE/ASE Recommendations for image acquisition and display using three-dimensional echocardiography. Eur Heart J Cardiovasc Imaging 2012;13:1-46.
Nagueh SF, Appleton CP, Gillebert TC, Adams DH, Agricola E, Buck T et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93.
Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 2006;355:251-9.
Melenovsky V, Borlaug BA, Rosen B, Hay I, Ferruci L, Morell CH et al. Cardiovascular Features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the Urban Baltimore Community. J Am Coll Cardiol. 2007;49:198-207.
Bonow RO. Radionuclide angiographic evaluation of left ventricular diastolic function. Circulation. 1991;84:I208-15.
Abidov A, Germano G, Hachamovitch R, Slomka P, Berman DS. Gated SPECT in assessment of regional and global left ventricular function: an update. J Nucl Cardiol. 2013;20:1118-43.
Schwitter J. Extending the frontiers of cardiac magnetic resonance. Circulation 2008;118:109-12.
Leong DP, De Pasquale CG, Selvanayagam JB. Heart failure with normal ejection fraction: the complementary roles of echocardiography and CMR imaging. JACC Cardiovasc Imaging 2010;3:409-20.
Raman SV, Simonetti OP. The CMRexamination in heart failure. Heart Fail Clin 2009;5:283-300. v.
Charoenpanichkit C, Hundley WG. The 20-year evolution of dobutamine stress cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2010;26:12-59.
Gulati A, Ismail TF, Jabbour A, Alpendurada F, Guha K, Ismail NA et al. The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy. Circulation. 2013;128:1623-33.
Masci PG, Francone M, Desmet W, Ganame J, Todiere G, Donato R et al. Right ventricular ischemic injury in patients with acute ST-segment elevation myocardial infarction: characterization with cardiovascular magnetic resonance. Circulation. 2010;122:1405-12.
Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy. The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014;35:2733-79.
Charron P, Arad M, Arbustini E, Basso C, Bilinska Z, Elliott P et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2010;31:2715-28.
Tocchetti CG, Ragone G, Coppola C, Basso C, Bilinska Z, Elliott P et al. Detection, monitoring, and management of trastuzumab-induced left ventricular dysfunction: an actual challenge. Eur J of Heart Failure 2012;14:130-7.
Jones AL, Barlow M, Barrett-Lee PJ, Canney PA, Gilmour IM, Robb SD et al. Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring. Br J Cancer 2009;100:684-92.
Hamirani YS, Jiji R, Salerno M, Wong A, Loffler A, Brenin CM et al. Delineation of anthracyclines and Herceptin induced cardiotoxicity using contrast enhanced CMR. J Cardiovasc Magn Reson 2014;16:P278.
Ylänen K, Poutanen T, Savikurki-Heikkilä P, Rinta-Kiikka I, Eerola A, Vettenranta K. Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer. J Am Coll Cardiol. 2013;61:1539-47.
MacDonald MR, Petrie MC, Hawkins NM, Petrie JR, Fisher M, McKelvie R et al. Diabetes, left ventricular systolic dysfunction, and chronic heart failure. Eur Heart J 2008;29:1224-40.
Camici PG, Prasad SK, Rimoldi OE. Stunning, hibernation and assessment of myocardial viability. Circulation. 2008;117:103-14.
Grenne B, Eek C, Sjøli B, DahlslettT, Uchto M, Hol PK et al. Acute coronary occlusion in non-ST-elevation acute coronary syndrome: outcome and early identification by strain echocardiography. Heart. 2010;96:1550-6.
Vanoverschelde JLJ, Pasquet A, Gerber B, Melin JA. Pathophysiology of myocardial hibernation. Implications for the use of dobutamine echocardiography to identify myocardial viability. Heart 1999;82:III1-7.
Afridi I, Kleiman NS, Raizner AE, Zoghbi WA. Dobutamine echocardiography in myocardial hibernation. optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation. 1995;91:663-70.
Camici PG, Prasad SK, Rimoldi OE. Contemporary reviews in cardiovascular medicine. stunning, hibernation, and assessment of myocardial viability. Circulation. 2008;117:103-14.
Underwood R, Bax JJ, vom Dahl J, Henein MY, van Rossum AC, Schwarz ER et al. Imaging techniques for the assessment of myocardial hibernation. Report of a Study Group of the European Society of Cardiology. Eur Heart J 2004;25:815-36.
John AS, Dreyfus GD, Pennell DJ. Images in cardiovascular medicine. Reversible wall thinning in hibernation predicted by cardiovascular magnetic resonance. Circulation. 2005;111:e24-5.
Bucciarelli-Ducci C, Wu E, Lee DC, Holly TA, Klocke FJ, Bonow RO. Contrast-enhanced cardiac magnetic resonance in the evaluation of myocardial infarction and myocardial viability in patients with ischemic heart disease. Curr Probl Cardiol. 2006;31:128-68.
Schuster A, Morton G, Chiribiri A, Perera D, Vanoverschelde JL, Nagel E. Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonance. J Am Coll Cardiol. 2012;59:359-70.
Marcu CB, Nijveldt R, Beek AM, Van Rossum AC. Delayed contrast enhancement magnetic resonance imaging for the assessment of cardiac disease. Heart Lung Circ 2007;16:70-8.
Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT et al. International Consensus Group on Cardiovascular Magnetic Resonance in Myocarditis. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol. 2009;53:1475-87.
Valle-Munoz A, Estornell-Erill J, Soriano-Navarro CJ, Holmvang G, Alakija P, Cooper LT et al. Late gadolinium enhancement-cardiovascular magnetic resonance identified coronary artery disease as the aetiology of left ventricular dysfunction in acute new-onset congestive heart failure. Eur J Echocardiogr 2009;10:968-74.
Greenwood JP, Maredia N, Younger JF, Holmvang G, Alakija P, Cooper LT et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet 2012;379:453-60.
Schwitter J, Wacker CM, Wilke N, Holmvang G, Alakija P, Cooper LT et al. Superior diagnostic performance of perfusion-cardiovascular magnetic resonance versus SPECT to detect coronary artery disease: The secondary endpoints of the multicentre multivendor MR-IMPACT II (Magnetic Resonance Imaging for Myocardial Perfusion Assessment inCoronary Artery Disease Trial). J CardiovascMagn Reson 2012;14:1-10.
Kim RJ, Wu E, Rafael A, Holmvang G, Alakija P, Cooper LT et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med 2000;343:1445-53.
Bondarenko O, Beek AM, Twisk JW, Visser CA, van Rossum AC. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. Eur Heart J 2008;29:2000-5.
Baksi AJ, Pennell DJ. T1 mapping in heart failure: from technique to prognosis, toward altering outcome. Circ Cardiovasc Imaging. 2013;6:861-3.
Sohal M, Duckett SG, Zhuang X, ShiW, Ginks M, Shetty A et al. A prospective evaluation of cardiovascular magnetic resonance measures of dyssynchronyin the prediction of response to cardiac resynchronization therapy. J Cardiovasc Magn Reson 2014;16:58.
Lockie T, Nagel E, Redwood S, Plein S. Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation 2009;119:1671-81.
Dilsizian V, Rocco TP, Freedman NM, Leon MB, Bonow RO. Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress redistribution imaging. N Engl J Med 1990;323:141-6.
Kitsiou AN, Srinivasan G, Quyyumi AA, Summers RM, Bacharach SL, Dilsizian V. Stress-induced reversible and mild-to-moderate irreversible thallium defects: are they equally accurate for predicting recovery of regional left ventricular function after revascularization? Circulation 1998;98:501-8.
Udelson JE, Coleman PS, Metherall J, Pandian NG, Gomez AR, Griffith JL et al. Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. Circulation. 1994; 89:2552-61.
Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate-enhanced Tc-99m sestamibi and Tl-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol. 2002;9:454-62.
Beller GA, Ragosta M. Decision making in multivessel coronary disease. JACC Cardiovasc Interv 2010;3:315-7.
Beanlands RS, Nichol G, Huszti E, Humen D, Racine N, Freeman M et al. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2). J AmColl Cardiol 2007;50:2002-12.
Schinkel AF, Bax JJ, Poldermans D, Elhendy A, Ferrari R, Rahimtoola SH. Hibernating myocardium: diagnosis and patient outcomes. Curr Probl Cardiol 2007;32:375-410.
Di Carli MF, Asgarzadie F, Schelbert HR, Brunken RC, Laks H, Phelps ME et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Lytle BW. Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999;33:750-8.
Nieman K, Cury RC, Ferencik M, Nomura CH, Abbara S, Hoffmann U et al. Differentiation of recent and chronic myocardial infarction by cardiac computed tomography. Am J Cardiol. 2006;98:303-8.
Ghostine S, Caussin C, Habis M, Habib Y, Clément C, Sigal-Cinqualbre et al. Noninvasive diagnosis of ischaemic heart failure using 64-slice computed tomography. Eur Heart J. 2008;29:2133-40.
Ten Kate GJ, Caliskan K, Dedic A, Meijboom WB, Neefjes LA, Manintveld OC et al. Computed tomography coronary imaging as a gatekeeper for invasive coronary angiography in patients with newly diagnosed heart failure of unknown aetiology. Eur J Heart Fail. 2013;15:1028-34.
Goetti R, Feuchtner G, Stolzmann P, Donati OF, Wieser M, Plass A et al. Delayed enhancement imaging of myocardial viability: low-dose high-pitch CT versus MRI. Eur Radiol. 2011;21:2091-9.
Myerson SG, d'Arcy J, Mohiaddin R, Greenwood JP, Karamitsos TD, Francis JM et al. Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation. 2012;126:1452-60.
Chan KM, Wage R, Symmonds K, Rahman-Haley S, Mohiaddin RH, Firmin DN et al. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson. 2008;10:61.
Barone-Rochette G, Piérard S, De Meester de Ravenstein C, Seldrum S, Melchior J, Maes F et al. Prognostic significance of LGE by CMR in aortic stenosis patients undergoing valve replacement. J Am Coll Cardiol. 2014;64:144-54.
Karamitsos TD, Myerson SG. The role of cardiovascular magnetic resonance in the evaluation of valve disease. Prog Cardiovasc Dis. 2011;54:276-86.
Bucciarelli-Ducci C, Azevedo CF. On fibrosis, prognosis, and the unique role of CMR: a paradigm shift from 'bright is dead' to 'bright is bad'. J Am Coll Cardiol. 2014;64:144-54.
Kilner PJ, Geva T, Kaemmerer H, Trindade PT, Schwitter J, Webb GD. Recommendations for cardiovascular magnetic resonance in adults with congenital heart disease from the respective working groups of the European Society of Cardiology. Eur Heart J 2010;31:794-805.
Schwitter J, Arai AE. Assessment of cardiac ischaemia and viability: role of cardiovascular magnetic resonance. Eur Heart J 2011;32:799-809.
Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461-74.
Maceira AM, Joshi J, Prasad SK, Moon JC, Perugini E, Harding I et al. Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation. 2005;111:186-93.
Wijns W, Kohl P, Danchin N, Di Mario C, Falk V, Folliguet T et al. Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association for Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2010;31:2501-55.
Velazquez EJ, Lee KL, Deja MA, Jain A, Sopko G, Marchenko A et al. for the STICH Investigators. Coronary-Artery Bypass Surgery in Patients with Left Ventricular Dysfunction. N Engl J Med 2011;364:1607-16.
Bonow RO, Maurer G, Lee KL, Holly TA, Binkley PF, Desvigne-Nickens P et al. for the STICH Trial Investigators. Myocardial Viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364:1617-25.
Castelvecchio S, Menicanti L. Left ventricular reconstruction: update to left ventricular aneurysm/reshaping techniques. Multimedia Manual of Cardiothoracic Surgery 2013; doi: 10.1093/mmcts/mmt002.
Weinsaft JW, Kim HW, Shah DJ, Klem I, Crowley AL, Brosnan R et al. Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction. J Am Coll Cardiol. 2008;52:148-57.
Dickstein K, Vardas PE, Auricchio A, Daubert JC, Linde C, McMurray J et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure. An update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur Heart J 2010;31:2677-87.
Scott PA, Rosengarten JA, Curzen NP, Morgan JM. Late gadolinium enhancement cardiac magnetic resonance imaging for the prediction of ventricular tachyarrhythmic events: a meta-analysis. Eur J Heart Fail. 2013;15:1019-27.
Roes SD, Borleffs CJ, van der Geest RJ, Westenberg JJ, Marsan NA, Kaandorp TA et al. Infarct tissue heterogeneity assessed with contrast-enhanced MRI predicts spontaneous ventricular arrhythmia in patients with ischemic cardiomyopathy and implantable cardioverter-defibrillator. Circ Cardiovasc Imaging. 2009;2:183-90.
Daubert JC, Saxon L, Adamson PB, Auricchio A, Berger RD, Beshai JF et al. 2012 EHRA/HRS expert consensus statement on cardiac resynchronization therapy in heart failure: implant and follow-up recommendations and management. Europace 2012;14:1236-86.
Bleeker GB, Kaandorp TA, Lamb HJ, Boersma E, Steendijk P, de RoosA et al. Effect of posterolateral scar tissue on clinical and echocardiographic improvement after cardiac resynchronization therapy. Circulation. 2006;113:969-76.
Alpendurada F, Guha K, Sharma R, Ismail TF, Clifford A, Banya W et al. Right ventricular dysfunction is a predictor of non-response and clinical outcome following cardiac resynchronization therapy. J Cardiovasc Magn Reson. 2011;13:68.
Leyva F, Taylor RJ, Foley PW, Umar F, Mulligan LJ, Patel K et al. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy. J Am Coll Cardiol. 2012;60:1659-67.
Delgado V, Bax JJ. Assessmentof systolic dyssynchrony for cardiac resynchronization therapy is clinically useful. Circulation. 2011;123:640-55.
Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-49.
Bax JJ, Bleeker GB, Marwick TH, Molhoek SG, Boersma E, Steendijk P et al. Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy. J Am Coll Cardiol. 2004;44:1834-40.
Van Bommel RJ, Ypenburg C, Borleffs CJ, Delgado V, Marsan NA, Bertini M et al. Value of tissue Doppler echocardiography in predicting response to cardiac resynchronization therapy in patients with heart failure. Am J Cardiol. 2010;105:1153-8.
Yu CM, Fung WH, Lin H, Zhang Q, Sanderson JE, Lau CP. Predictors of left ventricular reverse remodeling after cardiac resynchronization therapy for heart failure secondary to idiopathic dilated or ischemic cardiomyopathy. Am J Cardiol. 2003;91:684-8.
Chung ES, Leon AR, Tavazzi L, Sun JP, Nihoyannopoulos P, Merlino J et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-16.
Bleeker GB, Bax JJ, Fung JW, van derWall EE, Zhang Q, Schalij MJ et al. Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapy. Am J Cardiol. 2006;97:260-3.
Soman P, Chen J. Left ventricular dyssynchrony assessment using myocardial single-photon emission CT. Semin Nucl Med. 2014;44:314-9.
Wang L, Wei HX, Yang MF, Guo J, Wang JF, Fang W et al. Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99 m sestamibi SPECT. Ann Nucl Med. 2013; 27:325-34.
Andersson LG, Wu KC, Wieslander B, Loring Z, Frank TF, Maynard C et al. Left ventricular mechanical dyssynchrony by cardiac magnetic resonance is greater in patients with strict vs nonstrict electrocardiogram criteria for left bundle-branch block. Am Heart J. 2013;165:956-63.
Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;34:2281-329.
